{
    "code": "02024397",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02024397",
    "time": "2022-10-07 07:04:36",
    "許可證字號": "衛署藥輸字第024397號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "115\/03\/03",
    "發證日期": "95\/03\/03",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "第一等級醫療器材原登錄字號": "",
    "第一等級醫療器材新登錄字號": "",
    "通關簽審文件編號": "DHA00202439700",
    "中文品名": "隆特明眼用懸浮液0.5%",
    "英文品名": "Lotemax Ophthalmic Suspension 0.5%",
    "適應症": "眼瞼結膜及眼球結膜、角膜及眼球前部構造等對類固醇有反應之發炎，如過敏性結膜炎，酒渣鼻角膜炎，表淺性點狀角膜炎，帶狀疱疹角膜炎，虹膜炎，睫狀體炎，以及其他感染性結膜炎等因需要減輕水腫與發炎而可接受類固醇之潛在風險者，及眼睛手術之發炎。",
    "劑型": "483點眼懸液劑",
    "包裝": "100公撮以下塑膠滴瓶裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "06須由醫師處方使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "LOTEPREDNOL ETABONATE",
    "限制項目": "02輸　入 55依本署89、12、12衛署藥字第0890035812號公告事項三經本署認定得免除銜接性試驗之新藥",
    "申請商名稱": "1206501100  博士倫股份有限公司",
    "申請商地址": "台北市大安區敦化南路2段95號16樓",
    "主製造廠": [
        {
            "製造廠名稱": "FUS0369000  BAUSCH &amp; LOMB INCORPORATED",
            "製造廠廠址": "8500 HIDDEN RIVER PARKWAY TAMPA, FLORIDA 33637, U.S.A.",
            "製造廠公司地址": "",
            "製造廠國別": "UNITED STATES",
            "製程": ""
        }
    ],
    "次製造廠": [
        {
            "製造廠名稱": "6233082272  新竹物流股份有限公司",
            "製造廠廠址": "新竹縣新豐鄉松柏村德昌街228號",
            "製造廠公司地址": "",
            "製造廠國別": "TAIWAN",
            "製程": "二級包裝廠"
        }
    ],
    "CCC號列": "30043200002 其他醫藥製劑，含有腎上腺皮質類固醇荷爾蒙及其衍生物或結構式類似者Other medicaments, containing corticosteroid hormones, their derivatives or structural analogues",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "6804008710",
            "成分名稱": "LOTEPREDNOL ETABONATE",
            "含量描述": "",
            "含量": "5.0000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "Lotemax隆特明眼用懸浮液中文仿單p2_10805_20190927-108-09-27(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02024397&Seq=004&Type=9"
        },
        {
            "title": "Lotemax隆特明眼用懸浮液中文仿單p1_10805_20190927-108-09-27(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02024397&Seq=003&Type=9"
        },
        {
            "title": "020243970002.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02024397&Seq=002&Type=9"
        },
        {
            "title": "藥輸字第024397號_Lotemax隆特明眼用懸浮液外盒(中文小標)_20201023-109-10-23(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02024397&Seq=003&Type=8"
        },
        {
            "title": "藥輸024397_Lotemax隆特明眼用懸浮液外盒與中文小標-108-09-27(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02024397&Seq=002&Type=8"
        },
        {
            "title": "020243970001.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02024397&Seq=001&Type=8"
        }
    ]
}